CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 11 enrolled
Drug / intervention
Closed-loopdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00811317
NCT00811317N/ACompleted
CompareCT.gov

Closed-loop Glucose Control for Automated Management of Type 1 Diabetes

Boston University Charles River Campus·interventional·Posted Dec 18, 2008·Updated Oct 25, 2017

In Brief

A clinical study evaluating Closed-loop for Type 1 Diabetes. Completed, enrolled 11 participants across 1 site.

Detailed Summary

We hypothesize that our integrated closed-loop glucose-control system can provide effective, tight, and safe blood glucose (BG) control in type 1 diabetes, thereby establishing the feasibility of closed-loop BG control.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsType 1 Diabetes
CountriesUnited States
CollaboratorsMassachusetts General Hospital, Juvenile Diabetes Research Foundation

Timeline

N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedDec 18, 2008
Enrollment StartMay 1, 2008
Primary CompletionOct 1, 2009
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 17.5 years ago

Interventions

Closed-loopdevice

Computer algorithm developed by Firas El-Khatib and Edward Damiano at Boston University that controls sub-cutaneous infusion of insulin and glucagon to regulate blood glucose to target